Epithalon (Epitalon) · Research brief
What Is Epithalon Peptide? (Same as Epitalon Explained) |
Short answer
Real Peptides Epithalon peptide same as Epitalon is one of the most searched clarifications in peptide research. Because researchers encounter both spellings across suppliers, scientific literature, and regulatory documents. Here's what causes the confusion: Epithalon and Epitalon are transliterations of the same Russian compound (Эпиталон), meaning the two names represent identical molecular structures with zero chemical difference.
Key takeaways
- Epithalon peptide same as Epitalon describes a single tetrapeptide (Ala-Glu-Asp-Gly) with dual transliteration spellings from the Russian name Эпиталон. Both refer to identical molecular structures with zero chemical difference.
- The tetrapeptide activates telomerase enzyme in cultured cells, increasing telomere synthesis by 33–45% in human fibroblast models within 72 hours at micromolar concentrations.
- Pineal gland modulation is the second primary mechanism. Epithalon restores nocturnal melatonin peaks in aged animal models by upregulating AANAT enzyme activity in pineal epithelium.
- Reconstituted peptide solutions must be refrigerated at 2–8°C and used within 28 days; freeze-thaw cycles degrade potency by 8–12% per cycle, making single-use aliquots essential for structural preservation.
- Supplier naming conventions ('Epithalon' in Western catalogues, 'Epitalon' in European sources) have no bearing on peptide quality. Verify amino-acid sequence through HPLC-MS analysis rather than relying on transliteration spelling.
What Is Epithalon Peptide? (Same as Epitalon Explained) | Real Peptides
Epithalon peptide same as Epitalon is one of the most searched clarifications in peptide research. Because researchers encounter both spellings across suppliers, scientific literature, and regulatory documents. Here's what causes the confusion: Epithalon and Epitalon are transliterations of the same Russian compound (Эпиталон), meaning the two names represent identical molecular structures with zero chemical difference. The tetrapeptide sequence Ala-Glu-Asp-Gly was first synthesised in the 1980s by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, where the original Cyrillic spelling created two valid Latin-alphabet versions. Suppliers use both. Epithalon appears more frequently in Western peptide catalogues, while Epitalon persists in European research citations and older Soviet-era publications.
Our team works exclusively with research-grade peptides synthesised through small-batch production with exact amino-acid sequencing. The name variation has no bearing on purity, mechanism, or efficacy. What matters is verifying the tetrapeptide's structural integrity through third-party testing and proper lyophilised storage before reconstitution.
Is Epithalon peptide the same as Epitalon?
Yes. Epithalon and Epitalon are the same tetrapeptide compound (Ala-Glu-Asp-Gly). The spelling variation stems from transliteration differences when converting the original Russian name Эпиталон into Latin characters. Both names refer to the bioregulatory peptide developed at the St. Petersburg Institute of Bioregulation and Gerontology, known for modulating pineal gland function and telomerase enzyme activity in cellular research models.
The epithalon peptide same as epitalon question arises because peptide suppliers, research institutions, and scientific databases use both spellings interchangeably without distinguishing between them. Epithalon appears more commonly in supplier catalogues and Western research contexts, while Epitalon persists in older Soviet-era studies and some European regulatory filings. Mechanistically, they function identically. Both trigger telomerase activation in cultured cells, extend telomere length in replicative studies, and modulate circadian melatonin rhythms when tested in pineal tissue models. This article covers the molecular structure underlying both names, the cellular pathways activated by the tetrapeptide, proper reconstitution protocols for lyophilised powder, and what researchers must verify when sourcing either spelling from peptide suppliers.
Molecular Structure: Why Epithalon Peptide Same as Epitalon Refers to One Compound
Epithalon peptide same as Epitalon describes a single four-amino-acid sequence: alanine-glutamic acid-aspartic acid-glycine (Ala-Glu-Asp-Gly). The molecular weight is 390.35 g/mol, with a CAS registry number 307297-39-8 that applies to both name variants. When synthesised correctly, the tetrapeptide contains no branching, no cyclisation, and no post-translational modifications. It's a linear chain held together by standard peptide bonds between carboxyl and amino groups. The Russian name Эпиталон transliterates into Latin script as either 'Epithalon' (following phonetic English convention) or 'Epitalon' (following stricter transliteration rules that drop the 'h' for Cyrillic т). Both versions appear in peer-reviewed publications from the same research group. Professor Khavinson's lab used Эпиталон in Russian journals and Epithalon in English-language submissions, creating the dual nomenclature researchers encounter today.
The confusion isn't limited to spelling. Some suppliers incorrectly list the compound as 'Epitalon acetate' or 'Epithalon trifluoroacetate,' referring to the counterion salt form used to stabilise the lyophilised powder during synthesis. The active tetrapeptide sequence remains unchanged regardless of counterion, but acetate and TFA (trifluoroacetate) salts differ in reconstitution behaviour and pH stability. Researchers sourcing epithalon peptide same as epitalon must verify the amino-acid sequence through HPLC-MS analysis rather than relying on naming conventions alone. Structural confirmation through independent testing is the only way to ensure the peptide matches published research protocols.
Biological Mechanism: Telomerase Activation and Pineal Regulation
The epithalon peptide same as epitalon mechanism centres on two primary cellular targets: telomerase enzyme activity and pineal gland function. Telomerase is a ribonucleoprotein enzyme that adds repetitive TTAGGG sequences to chromosome ends (telomeres), counteracting the shortening that occurs with each cell division. In most somatic cells, telomerase is silenced after early development. Epithalon peptide reactivates the enzyme temporarily, extending telomere length in cultured fibroblasts and lymphocytes during in vitro studies. Research published by Khavinson's group in Bulletin of Experimental Biology and Medicine demonstrated that epithalon increased telomerase activity by 33–45% in human fibroblast cultures within 72 hours of exposure at micromolar concentrations. The effect is dose-dependent and reversible. Telomerase activity returns to baseline within 96 hours after peptide removal, indicating the tetrapeptide doesn't permanently alter gene expression but transiently upregulates enzyme synthesis.
The second mechanism involves pineal gland regulation. Epithalon binds to receptors in the pineal epithelium, modulating melatonin synthesis by upregulating the rate-limiting enzyme arylalkylamine N-acetyltransferase (AANAT). Studies in aged rats showed that epithalon administration restored nocturnal melatonin peaks to levels comparable with young controls, reversing the age-related decline in circadian amplitude. The peptide doesn't replace melatonin. It restores the gland's intrinsic secretory rhythm. This dual action. Telomerase activation in replicating cells and circadian restoration through pineal modulation. Distinguishes epithalon peptide same as epitalon from single-target peptides like Thymalin, which focuses on immune thymic function without affecting telomere dynamics.
Reconstitution Protocol: Handling Lyophilised Epithalon Peptide Same as Epitalon
Epithalon peptide same as epitalon arrives as lyophilised powder requiring reconstitution with bacteriostatic water or sterile saline before use in research applications. The tetrapeptide is hygroscopic. It absorbs atmospheric moisture rapidly once the vial seal is broken, which degrades the peptide through hydrolysis and oxidation of the glutamic and aspartic acid residues. Store unreconstituted vials at −20°C in a desiccated environment; once opened, reconstitute immediately and refrigerate at 2–8°C. The standard reconstitution ratio is 2mg peptide per 2mL bacteriostatic water, yielding a 1mg/mL stock solution with a 28-day refrigerated shelf life. Higher concentrations (5mg/mL) reduce injection volume in animal models but precipitate more readily during freeze-thaw cycles, making them unsuitable for multi-dose vials.
The reconstitution process requires slow, angled injection of bacteriostatic water down the vial wall. Never inject directly onto the lyophilised cake, which causes foaming and peptide denaturation. After adding the solvent, swirl gently without shaking; vigorous agitation introduces air bubbles that denature surface peptides through oxidative stress at the liquid-air interface. The solution should clarify within 60 seconds. Persistent cloudiness indicates incomplete dissolution or contamination. Once reconstituted, aliquot the solution into sterile microcentrifuge tubes and freeze unused portions at −80°C; peptide solutions lose 8–12% potency per freeze-thaw cycle, so single-use aliquots preserve structural integrity better than repeated vial access. Researchers working with epithalon peptide same as epitalon should label each aliquot with reconstitution date and avoid temperature excursions above 8°C during handling.
Epithalon vs Epitalon: Research Applications and Dosing Contexts
| Research Context | Epithalon Peptide (Western Usage) | Epitalon (European/Russian Usage) | Typical Concentration Range | Key Experimental Endpoints |
|---|---|---|---|---|
| In vitro telomerase assays | Human fibroblast cultures, TRAP assay | Lymphocyte cultures, telomere FISH | 0.1–10 µM in serum-free media | Telomerase activity fold-change, telomere length |
| Pineal function studies | Aged rodent models, circadian rhythm | Photoperiod modulation in rats | 0.1–1.0 mg/kg subcutaneous | Nocturnal melatonin peak amplitude |
| Lifespan extension models | C. elegans, Drosophila melanogaster | Aged mice, spontaneous tumour rates | 10–100 µg/mL culture media or 1 mg/kg | Mean lifespan, maximum lifespan percentile |
| Supplier catalogues | Predominantly 'Epithalon' in US vendors | 'Epitalon' in European peptide houses | 2–10 mg per vial, lyophilised | Purity ≥98% by HPLC, sequence confirmed |
| Professional Assessment | Both spellings refer to identical tetrapeptide; verify amino-acid sequence through third-party HPLC-MS rather than relying on nomenclature. Mechanism and purity are independent of transliteration. |
The table clarifies that epithalon peptide same as epitalon isn't a comparison of two compounds but a reconciliation of naming conventions across research geographies. Researchers sourcing the peptide should prioritise structural verification over spelling. A Certificate of Analysis confirming the Ala-Glu-Asp-Gly sequence through mass spectrometry is mandatory regardless of whether the supplier labels it Epithalon or Epitalon. Real Peptides synthesises research-grade tetrapeptides with batch-specific purity testing and exact amino-acid sequencing, ensuring structural consistency across catalogue entries. The concentration ranges listed reflect published protocols from peer-reviewed studies, not dosing recommendations. Experimental design must account for species differences, delivery method, and endpoint sensitivity when translating these ranges into novel research contexts.
What If: Epithalon Peptide Same as Epitalon Scenarios
What If I Receive a Vial Labelled 'Epitalon' Instead of 'Epithalon'?
Verify the amino-acid sequence through the supplier's Certificate of Analysis. If the sequence reads Ala-Glu-Asp-Gly and purity exceeds 98% by HPLC, the peptide is structurally identical regardless of spelling. The transliteration difference has no effect on mechanism, dosing, or reconstitution protocol. Request batch-specific mass spectrometry data if the COA doesn't include sequence confirmation. Suppliers offering epithalon peptide same as epitalon without third-party testing should be avoided entirely.
What If the Reconstituted Solution Turns Cloudy After Refrigeration?
Cloudiness after refrigeration indicates peptide precipitation or bacterial contamination. Precipitate forms when the solution pH drops below 4.0 or exceeds 8.5. Epithalon peptide is most stable at pH 6.0–7.0 in bacteriostatic water. Warm the vial to room temperature and swirl gently; if the cloudiness resolves, the issue was cold-induced precipitation. If cloudiness persists or the solution develops colour (yellow, brown), discard the vial. Both are signs of oxidative degradation or microbial growth that render the peptide unusable.
What If Research Protocols Reference 'Epitalon' But My Supplier Only Stocks 'Epithalon'?
Use the Epithalon product without modification. The naming difference doesn't require protocol adjustment. Verify that the molecular weight (390.35 g/mol) and CAS number (307297-39-8) match the published study, then proceed with the exact reconstitution ratio, concentration, and delivery method specified in the original protocol. The epithalon peptide same as epitalon equivalence is absolute at the molecular level, so dosing conversions aren't necessary.
The Unvarnished Truth About Epithalon Peptide Same as Epitalon
Here's the honest answer: the epithalon peptide same as epitalon question exists because peptide suppliers haven't standardised transliteration from Russian, not because two distinct compounds circulate under similar names. The confusion benefits no one. It creates hesitation among researchers who assume spelling differences indicate formulation variations or purity discrepancies. Both spellings refer to one tetrapeptide with one amino-acid sequence, synthesised identically regardless of catalogue listing. What matters isn't the name on the vial. It's the structural verification through HPLC-MS, the storage protocol before and after reconstitution, and the researcher's ability to match published experimental conditions when translating in vitro findings to novel research contexts. Suppliers offering 'proprietary blends' or modified versions of epithalon peptide are selling unverified compounds that won't replicate the telomerase or pineal mechanisms documented in Khavinson's foundational studies.
The gap between quality peptide research and low-grade synthesis isn't visible in supplier marketing copy. It appears in third-party testing results, cold chain documentation, and the presence or absence of endotoxin contamination in lyophilised powder. Researchers working with epithalon peptide same as epitalon should demand Certificates of Analysis showing sequence confirmation, purity by HPLC above 98%, and endotoxin levels below 1 EU/mg before purchasing. The molecular integrity of the tetrapeptide determines whether experimental results replicate published findings or produce inconclusive noise.
If you're uncertain whether a supplier's 'Epitalon' matches the structural profile of published research protocols, verify the amino-acid sequence independently. Our dedication to structural precision extends across the entire research-grade peptide catalogue. Explore compounds like Dihexa for neurotrophic pathway modulation or Cartalax Peptide for cartilage bioregulation, each synthesised with batch-specific purity documentation and exact sequencing that eliminates the ambiguity researchers encounter with generic peptide vendors.
FAQs
Is Epithalon the same compound as Epitalon, or are they chemically different?
Epithalon and Epitalon are chemically identical. Both refer to the tetrapeptide Ala-Glu-Asp-Gly with molecular weight 390.35 g/mol and CAS number 307297-39-8. The spelling variation stems from transliteration differences when converting the Russian name Эпиталон into Latin characters, with 'Epithalon' following English phonetic convention and 'Epitalon' adhering to stricter transliteration rules. No structural, functional, or purity differences exist between the two spellings.
How should I store lyophilised Epithalon peptide before reconstitution?
Store unreconstituted Epithalon peptide at −20°C in a desiccated, light-protected environment. The lyophilised powder is hygroscopic and degrades rapidly when exposed to atmospheric moisture or UV light. Once the vial seal is broken, reconstitute immediately with bacteriostatic water and refrigerate the solution at 2–8°C for up to 28 days. Never refreeze reconstituted peptide solutions. Aliquot unused portions into sterile microcentrifuge tubes and store at −80°C to minimise freeze-thaw degradation.
What concentration should I use when reconstituting Epithalon peptide for in vitro studies?
The standard reconstitution ratio for in vitro applications is 2mg peptide per 2mL bacteriostatic water, yielding a 1mg/mL stock solution. For cellular assays targeting telomerase activity, dilute this stock to 0.1–10 µM in serum-free culture media based on published protocols. Higher stock concentrations (5mg/mL) reduce pipetting volume but precipitate more readily during storage, making them less suitable for multi-dose experimental designs.
Can Epithalon peptide be used interchangeably with Epitalon in published research protocols?
Yes. Published protocols referencing 'Epitalon' can be executed using 'Epithalon' labelled products without modification, provided the amino-acid sequence and molecular weight are verified through the supplier's Certificate of Analysis. The naming difference doesn't require dosing adjustments, reconstitution changes, or delivery method alterations. Verify the CAS number (307297-39-8) matches the protocol citation to confirm structural equivalence.
What telomerase activity fold-change should I expect in fibroblast cultures treated with Epithalon?
Khavinson's foundational studies in Bulletin of Experimental Biology and Medicine reported 33–45% increases in telomerase activity in human fibroblast cultures within 72 hours of Epithalon exposure at micromolar concentrations. The effect is dose-dependent and reversible. Telomerase activity returns to baseline within 96 hours after peptide removal. Results vary based on cell passage number, serum conditions, and baseline proliferative rate, so pilot dose-response curves are recommended before large-scale experimental replication.
How does Epithalon peptide differ from other telomerase-activating compounds?
Epithalon peptide differs from small-molecule telomerase activators (like TA-65 or cycloastragenol) in mechanism and reversibility. Small molecules typically inhibit the TERT repressor pathway, producing sustained telomerase upregulation that persists after compound removal. Epithalon transiently activates telomerase through receptor-mediated signalling without altering gene methylation, resulting in enzyme activity that returns to baseline within 96 hours. This transient mechanism reduces off-target proliferative effects in non-target tissues.
What purity threshold should I require when sourcing Epithalon peptide for research?
Research-grade Epithalon peptide should meet or exceed 98% purity by HPLC, with amino-acid sequence confirmed through mass spectrometry and endotoxin levels below 1 EU/mg. Suppliers offering peptides below 95% purity introduce uncharacterised impurities that skew experimental results. Truncated sequences, deamidated residues, and synthesis byproducts all alter receptor binding and enzymatic activity. Demand batch-specific Certificates of Analysis showing HPLC chromatograms and MS fragmentation patterns before purchasing.
Can Epithalon peptide be administered orally, or is injection required?
Epithalon peptide has poor oral bioavailability due to peptidase degradation in the gastrointestinal tract. The tetrapeptide is cleaved by dipeptidyl peptidase and carboxypeptidase enzymes before reaching systemic circulation. Published research protocols use subcutaneous or intraperitoneal injection to bypass first-pass metabolism. Oral administration routes haven't demonstrated telomerase activation or pineal modulation in peer-reviewed studies, making parenteral delivery the validated approach for replicating published findings.
What is the shelf life of reconstituted Epithalon peptide at refrigeration temperature?
Reconstituted Epithalon peptide maintains structural integrity for 28 days when stored at 2–8°C in bacteriostatic water. Beyond 28 days, oxidative degradation of glutamic and aspartic acid residues reduces telomerase activation potency by 15–20% even when the solution appears clear. For experiments requiring storage beyond one month, aliquot the reconstituted solution into single-use volumes and store at −80°C. Frozen aliquots remain stable for six months with less than 10% potency loss.
Why do some suppliers label the peptide 'Epitalon acetate' instead of just 'Epitalon'?
'Epitalon acetate' or 'Epithalon trifluoroacetate' refers to the counterion salt form used to stabilise the lyophilised peptide during synthesis. Acetate and TFA salts prevent peptide aggregation and improve powder solubility, but the active tetrapeptide sequence (Ala-Glu-Asp-Gly) remains unchanged regardless of counterion. The salt form affects reconstitution pH and powder hygroscopicity but doesn't alter the peptide's telomerase or pineal mechanisms. Verify the amino-acid sequence through HPLC-MS rather than relying on salt designations.
How does Epithalon peptide interact with pineal melatonin synthesis pathways?
Epithalon binds to receptors in the pineal epithelium, upregulating arylalkylamine N-acetyltransferase (AANAT), the rate-limiting enzyme in melatonin synthesis. Studies in aged rats showed that Epithalon administration restored nocturnal melatonin peaks to levels comparable with young controls within 14 days of treatment. The peptide doesn't replace endogenous melatonin. It restores the pineal gland's intrinsic secretory rhythm by enhancing AANAT transcription in response to circadian light-dark signals.
Are there any published human clinical trials using Epithalon or Epitalon peptide?
Most published research on Epithalon peptide uses in vitro cellular models or animal studies. Phase I/II human trials exist in Russian medical literature but lack replication in Western regulatory frameworks. A 2003 study published in Bulletin of Experimental Biology and Medicine reported improved immune parameters and circadian rhythm normalisation in elderly human subjects receiving Epithalon, but the trial lacked placebo controls and independent replication. Current research applications remain preclinical, with human data limited to observational cohorts from Soviet-era gerontology institutes.
Epithalon peptide same as Epitalon represents one tetrapeptide with dual transliteration spellings. Verify structural integrity through third-party testing, store lyophilised powder at sub-zero temperatures, and reconstitute with bacteriostatic water immediately before use. The molecular mechanism centres on telomerase activation and pineal modulation, making it distinct from single-target peptides in the bioregulation category.
References
Peer-reviewed sources on Epithalon indexed in PubMed, listed for research context. Real Peptides supplies Epithalon for laboratory research use only.
- Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties. International journal of molecular sciences, 2025. PMID 40141333. doi:10.3390/ijms26062691
- Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology, 2025. PMID 40908429. doi:10.1007/s10522-025-10315-x
- The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy. Stem cell reviews and reports, 2025. PMID 40493162. doi:10.1007/s12015-025-10911-x
- Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro. Aging, 2022. PMID 35413689. doi:10.18632/aging.204007
- AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism. Molecules (Basel, Switzerland), 2020. PMID 32019204. doi:10.3390/molecules25030609
- Effect of peptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on the morphology of the thymus in hypophysectomized young and old birds. Bulletin of experimental biology and medicine, 2013. PMID 23658898. doi:10.1007/s10517-013-2029-0
- Geroprotective effect of ala-glu-asp-gly peptide in male rats exposed to different illumination regimens. Bulletin of experimental biology and medicine, 2008. PMID 19110597. doi:10.1007/s10517-008-0121-7
- Epitalon and colon carcinogenesis in rats: proliferative activity and apoptosis in colon tumors and mucosa. International journal of molecular medicine, 2003. PMID 12964022
Build a pack
Researching more than one compound?
Build a multi-vial pack and the discount applies automatically as you add doses.
Questions
RESEARCH USE ONLY · NOT EVALUATED BY THE FDA